Arcadia Biosciences, Inc. (RKDA) is a publicly traded Basic Materials sector company. As of July 31, 2026, RKDA trades at $0.63 with a market cap of $1.38M and a P/E ratio of -0.11. RKDA moved +0.00% today. Year to date, RKDA is -70.93%; over the trailing twelve months it is -85.47%. Its 52-week range spans $0.59 to $6.71. Rallies surfaces RKDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RKDA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.63 |
| Market Cap | $1.38M |
| P/E Ratio | -0.11 |
| EPS | $-5.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.71 |
| 52-Week Low | $0.59 |
| Volume | 5.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.76M |
| Net Income | $-9.28M |
| Gross Margin | 34.51% |
RKDA analyst coverage data. Average price target: $0.00.